is semaglutide hard on your kidneys Recent medical milestones include the 2025 FDA approval of Ozempic (semaglutide) specifically to slow the progression of chronic kidney disease (CKD) in patients with type 2 diabetes. Clinical trials Ozempic Drug Semaglutide Could Protect

Because GLP-1 medications can slow digestion and affect appetite, choosing compact, familiar options within high-protein snacks often feels more comfortable and predictable in the body

Survodutide (BI 456906) is a novel subcutaneous GCGR/GLP-1R dual agonist in development for the treatment of people with type 2 diabetes, obesity and non-alcoholic steatohepatitis (NASH)

Artificial pancreas or hybrid close loop systems are game changers for patients with type I diabetes

Understanding these differences helps avoid metabolic adaptation and ensures consistent results

Whether youre thinking about stopping semaglutide, planning for pregnancy, or just have questions about your options, were here to help